| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.37 | 0.03 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.35 | 0.03 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.25 | 0.04 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |